Advanced search
Publication Cover
Modern Rheumatology Volume 26, 2016 - Issue 6
Journal homepage
151
Views
6
CrossRef citations to date
0
Altmetric
Letter to the Editor

A unique case of polymyositis with anti-signal recognition particle antibody complicated by subacute interstitial lung disease and subluxing arthropathy, resembling anti-synthetase syndrome

Hironari HanaokaDivision of Rheumatology, Department of Internal Medicine, Correspondence[email protected]
,
Yuko KanekoDivision of Rheumatology, Department of Internal Medicine,
,
Shigeaki SuzukiDepartment of Neurology, Keio University School of Medicine, Tokyo, Japan, and
,
Tetsuya TakadaDivision of Rheumatology, Department of Internal Medicine,
,
Michito HirakataDivision of Rheumatology, Department of Internal Medicine,
,
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine,
&
Masataka KuwanaDivision of Rheumatology, Department of Internal Medicine, ;Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan
 show all
Pages 979-980 | Received 29 Aug 2015, Accepted 01 Dec 2015, Published online: 16 Feb 2016
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
"A unique case of polymyositis with anti-signal recognition particle antibody complicated by subacute interstitial lung disease and subluxing arthropathy, resembling anti-synthetase syndrome." Modern Rheumatology, 26(6), pp. 979–980

Conflict of interest

HH has received consulting fees from AstraZeneca. YK has received lecture fees from AbbVie, Eisai, Chugai, Bristol-Myers, Astellas, Mitsubishi Tanabe, Pfizer, Janssen, and UCB. TT has received grants from Abbott, Astellas, Bristol-Myers, Chugai, Daiichi Sankyo, Eisai, Mitsubishi Tanabe, Pfizer, Sanofi, Santen, Takeda, Teijin, AbbVie, Asahi Kasei, and Taisho Toyama; lecture fees from Abbott, Bristol-Myers, Chugai, Eisai, Janssen, Mitsubishi Tanabe, Pfizer, Takeda, Astellas, and Daiichi Sankyo; and consulting fees from AstraZeneca, Eli Lilly, Novartis, Mitsubishi Tanabe, Asahi Kasei, AbbVie, and Daiichi Sankyo. SS, TT, MH, and MK have no conflict of interest.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.